Proteasome activity modulates amyloid toxicity
Open Access
- 12 February 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in FEMS Yeast Research
- Vol. 22 (1)
Abstract
Alzheimer's disease (AD) is responsible for 60%–80% of identified cases of dementia. While the generation and accumulation of amyloid precursor protein (APP) fragments is accepted as a key step in AD pathogenesis, the precise role of these fragments remains poorly understood. To overcome this deficit, we induced the expression of the soluble C-terminal fragment of APP (C99), the rate-limiting peptide for the generation of amyloid fragments, in yeast that contain thermosensitive mutations in genes encoding proteasome subunits. Our previous work with this system demonstrated that these proteasome-deficient yeast cells, expressing C99 when proteasome activity was blunted, generated amyloid fragments similar to those observed in AD patients. We now report the phenotypic repercussions of inducing C99 expression in proteasome-deficient cells. We show increased levels of protein aggregates, cellular stress and chaperone expression, electron-dense accumulations in the nuclear envelope/ER, abnormal DNA condensation, and an induction of apoptosis. Taken together, these findings suggest that the generation of C99 and its associated fragments in yeast cells with compromised proteasomal activity results in phenotypes that may be relevant to the neuropathological processes observed in AD patients. These data also suggest that this yeast model should be useful for testing therapeutics that target AD-associated amyloid, since it allows for the assessment of the reversal of the perturbed cellular physiology observed when degradation pathways are dysfunctional.Keywords
Funding Information
- FRFCE
- Kidney Research UK (DK79307)
- National Institutes of Health (GM131732)
- National Institutes of Health (R00 GM086603)
This publication has 112 references indexed in Scilit:
- Interactions of Pathological Hallmark ProteinsJournal of Biological Chemistry, 2011
- Septin structure and function in yeast and beyondTrends in Cell Biology, 2011
- End-Labeling and Analysis of Spo11-Oligonucleotide Complexes in Saccharomyces cerevisiae2009
- Cell cycle re-entry mediated neurodegeneration and its treatment role in the pathogenesis of Alzheimer's diseaseNeurochemistry International, 2009
- Reactive oxygen species and yeast apoptosisBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2008
- Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memoryNature Medicine, 2008
- Proteomic analysis of the amyloid precursor protein fragment C99: expression in yeastAnalytical Biochemistry, 2007
- Roles of amyloid β-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairmentFree Radical Biology and Medicine, 2007
- Free radicals and antioxidants in normal physiological functions and human diseaseThe International Journal of Biochemistry & Cell Biology, 2007
- RAGE and amyloid-β peptide neurotoxicity in Alzheimer's diseaseNature, 1996